Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study-Reference-Cited by-同舟云学术

Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

Published:2000-07 Issue:9227 Volume:356 Page:359-365
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hansson Lennart,Hedner Thomas,Lund-Johansen Per,Kjeldsen Sverre Erik,Lindholm Lars H,Syvertsen Jan Otto,Lanke Jan,de Faire Ulf,Dahlöf Björn,Karlberg Bengt E

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. The Nordic Diltiazem Study: an intervention study in hypertension comparing calcium antagonist based treatment with conventional therapy;Blood Press,1993

2. The 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting;J Hypertens,1989

3. Single‐drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo;Materson;N Engl J Med,1993

4. Left ventricular hypertrophy: epidemiological insights from the Framingham Heart Study;Levy;Drugs,1988

5. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study;Levy;N Engl J Med,1990

Cited by 781 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agreement Between Mega-Trials and Smaller Trials;JAMA Network Open;2024-09-06

2. Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines;Hypertension;2024-05

3. Ischemic Heart Disease;Hypertension;2024

4. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26

5. First-line diuretics versus other classes of antihypertensive drugs for hypertension;Cochrane Database of Systematic Reviews;2023-07-13